Literature DB >> 8766067

[0.15 mg clonidine as oral premedication in retrobulbar anesthesia].

J Weindler1, A Rippa, T Kiefer, A Burg, K W Ruprecht.   

Abstract

BACKGROUND: In the present clinical study, oral premedication of 0.15 mg clonidine has been explored with view to anxiolytic effects and physiological stress parameters.
METHODS: The study involved 44 patients of ASA-class I-III, all scheduled to undergo ophthalmological surgery under retrobulbar anesthesia (RBA). One hour before RBA 22 patients received 0.15 mg clonidine and 22 patients placebo p.o. The following parameters were assessed at different times perioperatively: oxygenation (SpO2), heart rate, blood pressure, intraocular pressure and anxiety. Anxiolysis was determined using the Erlanger Anxiety Scale.
RESULTS: There were no significant differences among the groups in SpO2 and heart rate. Significantly decreased blood pressures were measured after clonidine premedication (p < 0.01). In contrast to clonidine after placebo the preoperative anxiety increased. Right before operation anxiety was decreased significantly (p < 0.01) by clonidine compared to placebo.
CONCLUSIONS: In our opinion, oral clonidine (0.15 mg) is useful for premedication of surgery under RBA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8766067     DOI: 10.1055/s-2008-1035255

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  2 in total

1.  [Does fentanyl or midazolam improve patient's comfort and cooperation when given for regional catheter placement? A randomized, controlled and double-blind trial].

Authors:  A M Morin; F G Vasters; H Wulf; G Geldner; C Kratz; U Hedderich; A Kussin; G Eisenhardt; L H J Eberhart
Journal:  Anaesthesist       Date:  2004-10       Impact factor: 1.041

Review 2.  [Local anesthesia in ophthalmic surgery].

Authors:  J Weindler; M Weindler; K W Ruprecht
Journal:  Ophthalmologe       Date:  2004-08       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.